OUR TOPICAL ANTI-WRINKLE PRODUCT FEATURING A NEW NEUROTOXIN ACTIVE
The topical concentrate features a synthetic biomimetic peptide of a cone snail toxin, developed by a Swiss biotech company. Our concentrate combines the latest pharmaceutical technology with the formulation expertise of SBV, creating a first-in-class topical alternative to surgical procedures. The product will relax facial muscles without blocking movement and provide instant skin smoothing. Currently in the final stages of R&D with a product launch scheduled for early 2015.
The core synthetic mimetic biopeptide is patented by Atheris Laboratories, a Swiss biotechnology company. The next generation versions of the biopeptide are joint efforts between the Company and Atheris Laboratories with the patents owned by the Company. We have exclusive usage rights.
The Conversation Agency is an award-winning, global marketing and advertising agency that prides itself on its “new traditional” approach. The team is made up of a diverse group of people – with a diverse range of skill-sets – providing grounded expertise in today’s evolving marketplace.